NCT06771505 SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)
| NCT ID | NCT06771505 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Short Bowel Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-15 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-01-15 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with short bowel syndrome have an impact on their quality of life because they need temporary or permanent parenteral nutritional support. The quality of life of these patients has been the subject of several studies and assessment tools exist, such as the Short Bowel Syndrome Quality of Life (SBS QoL). This tool may seem complex and tedious to use in everyday practice. However, it is important to regularly assess the quality of life of these patients. This is why the investigators are proposing to create a new tool for more rapid assessment of the quality of life of patients with short bowel syndrome.
Eligibility Criteria
Inclusion Criteria: * Age 18 or over * Patient able to read and speak French * Patient suffering from short bowel syndrome Exclusion Criteria: * Known cognitive disorders
Contact & Investigator
Charlotte BERGOIN, Doctor
PRINCIPAL INVESTIGATOR
Service d'hépato-gastro-entérologie et Assistance nutritionnelle - Hôpital Lyon Sud - CHLS
Frequently Asked Questions
Who can join the NCT06771505 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Short Bowel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06771505 currently recruiting?
Yes, NCT06771505 is actively recruiting participants. Contact the research team at charlotte.bergoin@chu-lyon.fr for enrollment information.
Where is the NCT06771505 trial being conducted?
This trial is being conducted at Pierre-Bénite, France.
Who is sponsoring the NCT06771505 clinical trial?
NCT06771505 is sponsored by Hospices Civils de Lyon. The principal investigator is Charlotte BERGOIN, Doctor at Service d'hépato-gastro-entérologie et Assistance nutritionnelle - Hôpital Lyon Sud - CHLS. The trial plans to enroll 100 participants.